Strategic objectives and key achievements

Transcription

1 Strategic objectives and key achievements 6 October 2011 Dr. J. Gabriel Beechinor Director of Veterinary Medicines Slide 1

2 IMB Vision To be recognised as a centre of excellence for both the quality and scientific rigour we bring to the work we do and the efficient manner in which it is completed Slide 2

3 Our values Acting always in the best interests of patients and consumers Operating to the highest standards of scientific quality and decision-making Behaving with integrity, impartiality and transparency in our dealings with all stakeholders Treating stakeholders and each other with dignity and respect at all times Slide 3

4 IMB Strategic Plan ns/publications/ Irish-Medicines- Board-Strategic- Plan aspx `````````` Slide 4

5 Achievements of the strategic plan Effective risk management and improving consumer safety Effective regulation through the ongoing development of our work-force and non-staff resources Effective communication with all stakeholders Slide 5

6 Operating environment Legislation - changes expected Public & animal health Availability of veterinary medicines Antimicrobial resistance New technologies Communication EudraPharm, EudraVigilance; transparency; risk communication Constructive partnerships Self-financing but regulated Slide 6

7 Strategic goals 1. Enhance product safety by effective risk management and market surveillance 2. Deliver clear, relevant and timely communications 3. Improve service delivery 4. Influence legislation and policy development at EU and international levels 5. Build future capabilities Slide 7

8 Goal 1 Work with healthcare professional bodies and universities to enhance knowledge Contribute to initiatives on monitoring of antimicrobial usage Further develop work-sharing with other authorities Submit MRL applications for needed medicines Slide 8

9 Goal 2 Encourage engagement of the public in the activities of the IMB Improve the accessibility, relevance and public awareness of information Position the IMB as an effective, strong and robust regulator Slide 10

10 Goal 3 Meet agreed timelines for all licensing, inspection and monitoring procedures Increase IMB contribution to EU licensing, inspection and monitoring procedures Define regulatory areas of additional special interest, while recognising the requirement for a general service offering Slide 12

11 Goal 4 Influence the strategic direction of new legislation Continue to maintain a high profile in EU committees responsible for managing the network and contributing to effectiveness of regulatory systems Slide 14

12 Goal 5 Further embed quality and risk management within the organisation Develop organisation-wide scientific expertise matrix for future needs Improve the management of knowledge in the organisation Ensure income is aligned with cost Slide 16

13 Progress thus far Goal 1 contact with universities initiated; lectures planned; annual sales of antimicrobials captured, work-sharing on variations extended to the Netherlands Goal 2 website format and content updated, IMB contributes regular articles to professional journals Slide 18

14 Progress thus far Goal 3 monthly monitoring of process KPIs, half-yearly monitoring of riskmanagement policies Goal 4 IMB participates in HMA Task Force on legislation; IMB contributes to policy discussion and formation Goal 5 Knowledge management review of department undertaken, proactive steps taken to improve knowledge sharing Slide 19

15 Conclusions Tosagh maith, leath na h-oibre Veterinary Medicines Department continues to perform well as evidenced by: Overall output Amongst top 5 European agencies for RMS rapporteurships Quality of our work Value of information provided on veterinary medicines Slide 20